In the October 8, 2014, Federal Register, FDA published its
determination that LUPRON DEPOT (leuprolide acetate for depot
suspension), an injectable vial containing 3.75 milligrams of the
drug, was not withdrawn from sale for reasons of safety or
effectiveness.
The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.